Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Astragaloside IV Attenuates Experimental Autoimmune Encephalomyelitis of Mice by Counteracting Oxidative Stress at Multiple Levels.
Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination.
Probenecid Application Prevents Clinical Symptoms and Inflammation in Experimental Autoimmune Encephalomyelitis.
The Elderly Person With Multiple Sclerosis: Clinical Implications for the Increasing Lifespan.
Advances in the management of MS symptoms: recently proposed clinical management algorithms.
LOTUS, a possible endogenous inhibitor of axonal degeneration, as a new biomarker for multiple sclerosis.
CCR5 blockade for neuroinflammatory diseases - beyond control of HIV.
Sodium channel blockers for neuroprotection in multiple sclerosis.
Roche hits multiple sclerosis landmarks.
Epidemiology and genetic aspects of multiple sclerosis in India.
The Challenges, Advantages, and Future of Phenome-Wide Association Studies.
Acute disseminated encephalomyelitis: an evaluation of 15 cases in childhood.
Association of TNFAIP3 and TNFRSF1A variation with multiple sclerosis in a German case-control cohort.
Can neurotrophic cytokines help to regenerate the mammalian central nervous system?
Neuregulin/ErbB Signaling in Developmental Myelin Formation and Nerve Repair.
Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis.
Combining Double Fluorescence In Situ Hybridization with Immunolabelling for Detection of the Expression of Three Genes in Mouse Brain Sections.
Assessment of cortical damage in early multiple sclerosis with quantitative T2 relaxometry.
DNA Subtraction of In Vivo Selected Phage Repertoires for Efficient Peptide Pathology Biomarker Identification in Neuroinflammation Multiple Sclerosis Model.
Television-provoked epilepsy in children: a follow-up survey from Isfahan, Iran.
The disruption of mitochondrial axonal transport is an early event in neuroinflammation.
Axon regeneration impediment: the role of paired immunoglobulin-like receptor B.
Comparative Neuroregenerative Effects of C-Phycocyanin and IFN-Beta in a Model of Multiple Sclerosis in Mice.
Hydrogen sulfide controls peripheral nerve degeneration and regeneration: a novel therapeutic strategy for peripheral demyelinating disorders or nerve degenerative diseases.
Protection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs.
Pages
« first
‹ previous
…
689
690
691
692
693
694
695
696
697
…
next ›
last »